KOPP INVESTMENT ADVISORS LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 128 filers reported holding INTERSECT ENT INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
KOPP INVESTMENT ADVISORS LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q3 2019$1,146,000
-62.1%
67,390
-49.3%
2.11%
-38.9%
Q2 2019$3,025,000
-41.6%
132,924
-17.5%
3.45%
-17.8%
Q1 2019$5,180,000
+13.7%
161,108
-0.3%
4.19%
-5.7%
Q4 2018$4,554,000
-15.1%
161,587
-13.4%
4.44%
-1.6%
Q3 2018$5,364,000
-25.2%
186,561
-2.5%
4.51%
-32.9%
Q2 2018$7,167,000
-7.3%
191,382
-2.7%
6.72%
-14.5%
Q1 2018$7,733,000
+18.2%
196,776
-2.6%
7.86%
+20.0%
Q4 2017$6,543,000
-6.4%
201,943
-10.0%
6.55%
+2.3%
Q3 2017$6,989,000
-17.2%
224,372
-25.7%
6.40%
-15.2%
Q2 2017$8,440,000
+39.3%
301,963
-14.5%
7.56%
+27.6%
Q1 2017$6,058,000
+39.9%
353,251
-1.3%
5.92%
+29.5%
Q4 2016$4,329,000
+14.5%
357,795
+49.9%
4.57%
+22.3%
Q3 2016$3,781,000
-54.7%
238,698
-63.0%
3.74%
-15.8%
Q2 2016$8,341,000
-10.2%
645,078
+32.0%
4.44%
-12.4%
Q1 2016$9,284,000
-26.1%
488,643
-12.5%
5.06%
-18.0%
Q4 2015$12,563,000
+22.4%
558,339
+27.2%
6.18%
+11.8%
Q3 2015$10,268,000
-14.2%
438,809
+5.0%
5.52%
+3.7%
Q2 2015$11,961,000
+461.8%
417,788
+406.8%
5.33%
+465.5%
Q1 2015$2,129,00082,4370.94%
Other shareholders
INTERSECT ENT INC shareholders Q2 2015
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders